Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Peringkat dalam Saham #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Harga Saham
$2.49
Kapitalisasi Pasar
$4.47M
Perubahan (1 hari)
-4.01%
Perubahan (1 tahun)
678.16%
Negara
MY
Perdagangan BioNexus Gene Lab Corporation (BGLC)

Kategori

Jumlah saham beredar untuk BioNexus Gene Lab Corporation (BGLC)
Jumlah saham beredar per September 2025: 1.80M
Menurut laporan keuangan terbaru dan harga saham BioNexus Gene Lab Corporation, jumlah saham beredar saat ini adalah 1.80M. Pada akhir December 2023, perusahaan memiliki 1.72M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk BioNexus Gene Lab Corporation (BGLC) dari 2016 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 1.80M 0.83%
2024 1.78M 3.47%
2023 1.72M 19.51%
2022 1.44M 0.99%
2021 1.43M 66.36%
2020 857.65K 19.16%
2019 719.74K 30.20%
2018 552.80K -11.11%
2017 621.90K 0.00%
2016 621.90K 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
376.00M 20,828.46%
US
707.30M 39,268.87%
US
80.10M 4,358.21%
US
2.84B 157,753.15%
CN
283.00M 15,652.00%
US